Hodgkin lymphoma, a rare but treatable blood cancer, primarily impacts younger individuals aged 20-40. Effective treatment is crucial, but so is the consideration of long-term health and quality of life for patients. Recent advancements in chemotherapy regimens have shown promise in reducing
The PROSPECT-Lung trial has officially commenced, heralding a significant advance in the quest to enhance treatment strategies for patients with resectable non-small cell lung cancer (NSCLC). This trial marks the inaugural endeavor of the newly established National Cancer Institute (NCI) Clinical
The findings from the late-breaking research presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition have brought new insights into the treatment of mantle cell lymphoma (MCL). The phase 3 study EA4151, conducted by the ECOG-ACRIN Cancer Research Group, investigated
New research conducted by the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has revealed a significant connection between accelerated aging and an increased risk of early-onset colorectal cancer. This groundbreaking study sheds light on the importance of
Mayo Clinic researchers have made a case for comprehensive TPMT genotyping across various ancestries to better predict drug response and minimize adverse reactions. Their recent discovery of the TPMT∗8 allele, a gene variant associated with reduced metabolism of thiopurine drugs, has revolutionary
Genital herpes continues to be a significant global health issue, affecting millions of individuals worldwide. Despite the high prevalence, the condition often remains under-discussed and inadequately addressed. While many individuals exhibit no or few symptoms, others suffer from painful genital
